PULM - Pulmatrix Inc Qarzning balans kapitallashuviga nisbati

Pulmatrix Inc (PULM) grafik logotipi

Pulmatrix, Inc. (PULM) tadqiqot va ishlanmalar (R&D) markazi tartibga soluvchi organlar uchun hujjatlarni tayyorlash bilan birga, zamburug'ga qarshi vositalarning klinik sinovlariga e'tibor qaratadi. Brendning pulmonologiya sohasidagi yuqori nufuzi shaxsiy dori yetkazib berish tizimiga asoslangan. Kompaniyaning innovatsion markazi o'pka patologiyalariga qarshi kurashishda iSPERSE texnologiyasiga tayanadi. Kompaniyaning qarzdorlikning kapitalga nisbati moliyaviy barqarorlikni namoyish etadi, bunda ushbu ko'rsatkich hozirda 0.00 darajasida turibdi.

PULM (Pulmatrix Corporation) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha

Pulmatrix Inc (PULM) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Pulmatrix, Inc.|PULM - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Pulmatrix Corporation|PULM - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Pulmatrix|PULM - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati pulmatrix.com|PULM - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Pulmatrix, Inc.|PULM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Pulmatrix Corp|PULM - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Pulmatrix Corporation
Kompaniyaning barcha koʻrsatkichlari tahlili:PULM Pulmatrix, Inc.
Pulmatrix Corp asosiy tovari

Ushbu koeffitsiyent qarz kapitalining bazaviy kapitalga nisbatan ulushini belgilab, kompaniyaning moliyaviy leveraj darajasini o'lchaydi. Ushbu metrikaning oshishi qarz yukining ortishidan dalolat bersa, kamayishi moliyaviy avtonomiyaning kuchayishini ko'rsatadi. Bazaviy kapitalga asoslangan joriy leveraj koeffitsiyentini tahlil qilish orqali Pulmatrix, Inc. (PULM) kompaniyasining inhalatsiya dori vositalarining qimmatbaho klinik sinovlari davridagi barqarorligini baholash mumkin. Barqaror tendentsiya R&D platformasining kreditorlarga kritik bog'lanib qolmasdan rivojlanish qobiliyatini tasdiqlaydi, bu esa tartibga soluvchi hujjatlarni tayyorlash jarayonida bankrotlik xavfini minimallashtiradi.

Pulmatrix, Inc. raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|China SXT Pharmaceuticals, Inc. (SXTC) - Qarzning balans kapitallashuviga nisbati|EPRX - Qarzlarning balans kapitallashuviga nisbati|BioHarvest - Qarzning balans qiymatiga nisbati|EXOZ: Balans kapitallashuviga qarzlar|oramed.com (ORMP) - Qarzning balans kapitallashuviga nisbati|ENTX (Entera Bio) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati HYFT|Qarzning balans qiymatiga nisbati ABVC BioPharma Inc.|Balans kapitallashuviga qarzlar CPIX|Balans kapitallashuviga qarzlar Quantum BioPharma Corp QNTM|Qarzning balans qiymatiga nisbati FibroGen, Inc. (FGEN)|telomirpharma.com - Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati Rani Therapeutics Inc (RANI)|SNYR - Qarzning sof aktivlarga nisbati|rallybio.com - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Lexaria Bioscience Corp.|Qarzning balans qiymatiga nisbati Pheton Holdings Limited (PTHL)|Qarzning balans qiymatiga nisbati Aptorum (APM)|Lyra Therapeutics (LYRA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Impact BioMedical, Inc. (IBO)|Balans kapitallashuviga qarzlar TNFA|cbdMD Inc. - Sof aktivlarga qarzlar|PainReform Ltd. (PRFX) - Qarzning balans kapitallashuviga nisbati|CYTO - Qarzning balans qiymatiga nisbati|LIPO (Lipella Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati OptiNose Inc|PIRS: Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar PROC|PTPI - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati qlsyy.net QLI|Qarzning balans qiymatiga nisbati SLRN (ACELYRIN)|TFF Pharmaceuticals Inc. - Balans kapitallashuviga qarzlar